Fairfield, Bush & Co.’s Eli Lilly & Co Position
Does Fairfield, Bush & Co. own Eli Lilly & Co (LLY)? Yes — 2.8K shares worth $3M (+1.45% of its 13F portfolio) as of Q1 2026, down from 2.8K shares the prior filed quarter.
Position Value
$3M
Q1 2026
Shares
2.8K
% of Portfolio
+1.45%
Quarters Held
28
currently held
Position History LLY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 2.8K | $3M | +1.45% |
| Q4 2025 | 2.8K | $3M | +1.61% |
| Q3 2025 | 3.0K | $2M | +1.16% |
| Q2 2025 | 2.8K | $2M | +1.24% |
| Q1 2025 | 2.8K | $2M | +1.44% |
| Q4 2024 | 2.7K | $2M | +1.24% |
| Q3 2024 | 2.7K | $2M | +1.44% |
| Q2 2024 | 2.3K | $2M | +1.25% |
| Q1 2024 | 2.1K | $2M | +0.99% |
| Q4 2023 | 2.1K | $1M | +0.72% |
| Q3 2023 | 1.9K | $1M | +0.67% |
| Q2 2023 | 26.5K | $12M | +3.42% |
| Q1 2023 | 26.7K | $9M | +3.23% |
| Q4 2022 | 1.6K | $595,222 | +0.39% |
| Q3 2022 | 992 | $321,000 | +0.23% |
| Q2 2022 | 405 | $131,000 | +0.08% |
| Q3 2021 | 3.0K | $693,000 | +0.23% |
| Q2 2021 | 24.3K | $6M | +1.52% |
| Q1 2021 | 24.3K | $5M | +1.30% |
| Q4 2020 | 24.3K | $4M | +1.20% |
| Q3 2020 | 24.4K | $4M | +1.15% |
| Q2 2020 | 24.4K | $4M | +1.43% |
| Q1 2020 | 24.6K | $3M | +1.42% |
| Q4 2019 | 24.6K | $3M | +1.19% |
| Q3 2019 | 24.6K | $3M | +0.95% |
| Q2 2019 | 24.6K | $3M | +0.93% |
| Q1 2019 | 24.6K | $3M | +1.06% |
| Q4 2018 | 24.6K | $3M | +0.98% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Fairfield, Bush & Co.’s full portfolio or all institutional holders of LLY.